On June 17, Praxis Precision Medicines rose 5.29% in regular trading, trading at $271.2/share, with Turnover of $22.19 million.
Within the Biotechnology sector where Praxis Precision Medicines belongs, individual stocks showed broad gains. Among individual stocks, uniQure NV up 70.12%, Lunai Bioworks up 57.12%, Azitra Inc up 44.76%, PTC Therapeutics up 7.36%, Gilead Sciences up 0.29%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)